Reviewed by The Peptide Dispatch Editorial Team · Last reviewed July 6, 2026
ACE-031 (ACE031) is a muscle peptide, at the discontinued stage in the published literature. Soluble activin receptor type IIB fusion protein that acts as a myostatin trap, promoting significant muscle growth.
Soluble activin receptor type IIB fusion protein that acts as a myostatin trap, promoting significant muscle growth.
| Research Status | Discontinued |
|---|---|
| Half-Life | ~12 days |
| Administration | Subcutaneous injection |
| Doses Reported in Published Studies | Research varies |
Decoy receptor that binds myostatin and other negative regulators of muscle mass.
Soluble activin receptor type IIB fusion protein that acts as a myostatin trap, promoting significant muscle growth.
Decoy receptor that binds myostatin and other negative regulators of muscle mass.
ACE-031 is at the following stage in the published literature: Discontinued. All information is for research and educational purposes only.
Reported half-life: ~12 days.
Reported administration route in the literature: Subcutaneous injection. This is not a recommendation for human use.
Educational content, not medical advice. Effects described are drawn from cited research in study subjects.